IPRAGLIFLOZIN

/static/temp/default.svg Search structure
Synonyms
Status
Molecule Category Free-form
ATC A10BK05
UNII 3N2N8OOR7X

Structure

InChI Key AHFWIQIYAXSLBA-RQXATKFSSA-N
Smiles OC[C@H]1O[C@@H](c2ccc(F)c(Cc3cc4ccccc4s3)c2)[C@H](O)[C@@H](O)[C@@H]1O
InChI
InChI=1S/C21H21FO5S/c22-15-6-5-12(21-20(26)19(25)18(24)16(10-23)27-21)7-13(15)9-14-8-11-3-1-2-4-17(11)28-14/h1-8,16,18-21,23-26H,9-10H2/t16-,18-,19+,20-,21+/m1/s1

Physicochemical Descriptors

Property Name Value
Molecular Formula C21H21FO5S
Molecular Weight 404.46
AlogP 2.15
Hydrogen Bond Acceptor 6.0
Hydrogen Bond Donor 4.0
Number of Rotational Bond 4.0
Polar Surface Area 90.15
Molecular species NEUTRAL
Aromatic Rings 3.0
Heavy Atoms 28.0

Pharmacology

Mechanism of Action Action Reference
Sodium/glucose cotransporter 2 inhibitor INHIBITOR PubMed PMDA
Targets EC50(nM) IC50(nM) Kd(nM) Ki(nM) Inhibition(%)
Transporter Electrochemical transporter SLC superfamily of solute carriers SLC05 family of sodium-dependent glucose transporters
7.4 7.38-8.4 - - -
EC50(nM) IC50(nM) Kd(nM) Ki(nM) Inhibition(%)
Homo sapiens
7.4 7.38-8.4 - - -

Target Conservation

Protein: Sodium/glucose cotransporter 2
Description: Sodium/glucose cotransporter 2
Organism : Homo sapiens
P31639 ENSG00000140675

Cross References

Resources Reference
ChEBI 134724
ChEMBL CHEMBL2018096
DrugBank DB11698
DrugCentral 4890
FDA SRS 3N2N8OOR7X
Guide to Pharmacology 9394
PubChem 10453870
SureChEMBL SCHEMBL337645
ZINC ZINC000038897728
CONTENTS